Sixth nerve palsy post intravitreal bevacizumab for AMD: a new possibly causal relationship and complication?
Park
Hee-Jung
HJ
Department of Ophthalmology, University of Florida, Gainesville 32610-0284, USA.
Guy
John
J
D020434:Abducens Nerve Diseases / Q000139:chemically induced* / Q000503:physiopathology; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D004948:Esotropia / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab